CCN(C(C)C)C(C)C.Cl.[S:11]([N:21]1[C:25]2=[N:26][CH:27]=[C:28]([CH2:30][NH2:31])[N:29]=[C:24]2[CH:23]=[CH:22]1)([C:14]1[CH:20]=[CH:19][C:17]([CH3:18])=[CH:16][CH:15]=1)(=[O:13])=[O:12].[C:32]([N:39]1[CH2:44][CH2:43][CH2:42][C@@H:41]([C:45](O)=[O:46])[CH2:40]1)([O:34][C:35]([CH3:38])([CH3:37])[CH3:36])=[O:33].CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F>C(Cl)Cl.O>[S:11]([N:21]1[C:25]2=[N:26][CH:27]=[C:28]([CH2:30][NH:31][C:45]([C@@H:41]3[CH2:42][CH2:43][CH2:44][N:39]([C:32]([O:34][C:35]([CH3:38])([CH3:37])[CH3:36])=[O:33])[CH2:40]3)=[O:46])[N:29]=[C:24]2[CH:23]=[CH:22]1)([C:14]1[CH:15]=[CH:16][C:17]([CH3:18])=[CH:19][CH:20]=1)(=[O:12])=[O:13]DIEA (7.7 mL, 44.3 mmol) was added to a solution of (5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-yl)methanamine hydrochloride (5 g, 14.7 mmol) in DCM (78 mL) and the reaction was stirred at ambient temperature for about 10 min followed by the addition of (R)-N-Boc-piperidine-3-carboxylic acid (3.38 g, 14.7 mmol, CNH-Technologies) and HATU (5.61 g, 14.7 mmol). The mixture was stirred for about 1 h, then water (30 mL) was added, and the layers were separated. The organic layer was washed with saturated aqueous NaHCO3 (30 mL) and brine (30 mL), dried over anhydrous MgSO4, filtered, and concd under reduced pressure. The crude material was purified by silica gel chromatography eluting with a gradient of 0-5% MeOH in DCM to afford crude (R)-tert-butyl 3-((5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-yl)methylcarbamoyl)piperidine-1-carboxylate (7.58 g, 94%): LC/MS (Table 1, Method b) Rt=2.30 min; MS m/z: 514 (M+H)+.
読み込み中…